Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

139
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
139
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

99
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
99
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

119
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
119
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

64
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
64
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

800
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
800
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

818
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
818

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multilingual Prediction of Cognitive Impairment with Large Language Models and Speech Analysis.

Brain sciences·2025
Same author

Predicting dementia from spontaneous speech using large language models.

PLOS digital health·2023
Same author

Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer's Disease Using Voice.

Brain sciences·2023
Same author

Investigating systematic bias in brain age estimation with application to post-traumatic stress disorders.

Human brain mapping·2019
Same author

Structure-Function Network Mapping and Its Assessment via Persistent Homology.

PLoS computational biology·2017
Same author

Mechanisms involved in ceramide-induced cell cycle arrest in human hepatocarcinoma cells.

World journal of gastroenterology·2007

Related Experiment Video

Updated: Jul 26, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.0K

PharmBERT: a domain-specific BERT model for drug labels.

Taha ValizadehAslani1, Yiwen Shi2, Ping Ren3

  • 1Department of Electrical and Computer Engineering, College of Engineering, Drexel University, Philadelphia, PA, USA.

Briefings in Bioinformatics
|June 15, 2023
PubMed
Summary
This summary is machine-generated.

PharmBERT, a specialized BERT model, excels at extracting information from human prescription drug labels. It outperforms existing models by being pretrained on domain-specific language, improving drug safety information retrieval.

Keywords:
BERTdrug labelnatural language processingpretraining

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

Related Experiment Videos

Last Updated: Jul 26, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.0K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

Area of Science:

  • Natural Language Processing
  • Computational Linguistics
  • Pharmacology

Background:

  • Human prescription drug labeling is crucial for safe and effective medication use.
  • Drug labels contain vital information like pharmacokinetics and adverse events.
  • Automated information extraction from these labels can enhance drug safety and interaction identification.

Purpose of the Study:

  • To highlight the unique linguistic characteristics of drug labels.
  • To introduce PharmBERT, a BERT model specifically pre-trained on drug label data.
  • To demonstrate PharmBERT's superior performance in NLP tasks within the drug label domain.

Main Methods:

  • Developed PharmBERT, a BERT model with domain-specific pretraining on drug labels.
  • Evaluated PharmBERT against vanilla BERT, ClinicalBERT, and BioBERT on multiple NLP tasks.
  • Analyzed PharmBERT's layers to understand the contribution of domain-specific pretraining.

Main Results:

  • PharmBERT significantly outperforms vanilla BERT, ClinicalBERT, and BioBERT in drug label NLP tasks.
  • Domain-specific pretraining is shown to be key to PharmBERT's enhanced performance.
  • Analysis provided insights into PharmBERT's understanding of linguistic nuances in drug labels.

Conclusions:

  • PharmBERT is a highly effective tool for information extraction from drug labels.
  • Domain-specific pretraining is essential for optimal performance in specialized text domains.
  • PharmBERT offers a promising approach for improving the accessibility and utility of drug information.